Scientist AI technology biotechnology medical research
September 30, 2026 | Delilah Garrett |

Press Coverage

For Rare Disease Marketing, Precision Starts with the Care Pathway

Rare disease marketing demands more than broad audience segments—it requires a precise understanding of the complex care pathways, signals, and relationships that shape diagnosis and treatment. CMI Media Group’s Rare Disease Center of Excellence combines boutique-level therapeutic expertise with advanced data, AI-enabled tools, media activation, and agency scale to help brands connect patients, caregivers, HCPs, and advocacy communities more effectively. Learn more about CMI’s expertise here in this Fierce Pharma article. 

Connect with CMI Media Group on LinkedIn.

For latest news and updates, follow us on Instagram, LinkedIn, and Facebook.

Questions? Thoughts? Ideas? Contact us.